The Effects of Cognitive-motor Dual-task Intervention on Fall Prevention Among Older Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorJinyao Wang

About this trial

1. Develop an evidence-based dual-task intervention programme incorporating gamification for fall risk reduction in older adults. 2. Examine the effects of the gamified dual-task intervention on fall risk in older adults. 3. Elucidate the underlying mechanisms of the optimal gamified dual-task intervention programme in reducing falls in older adults.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥ 65 years old;

Able to walk independently for at least 10 meters without obvious pain or difficulty;

Free from lower limb and foot deformities, wounds, ulcers, or other diseases, and capable of wearing flexible devices;

Scored as low or moderate fall risk on the Morse Fall Risk Assessment Scale;

Disqualifiers

Must rely on assistive walking devices or others to walk;

Individuals with color vision disorders, including various types of color blindness and color weakness;

Unable to correctly perform addition and subtraction operations;

Those allergic to the materials of research equipment;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Medium difficulty fixed priority group

    Behavioral

    During the intervention process, participants carried out cognitive and motor tasks simultaneously. They were told to divide attention equally between them and not prioritize one over the other.

  • Medium difficulty variable priority group

    Behavioral

    During the intervention process, participants performed medium-difficulty cognitive and motor tasks simultaneously. Participants alter focus between the motor task and the cognitive task every half of the intervention time.

Treatment groups

125 Participants
are divided into 2 treatment groups
Group A: Medium difficulty fixed priority groupExperimental treatment 1 intervention
Group B: Medium difficulty variable priority groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

The changes of Time up and go test from baseline to the end of the intervention

Time frame
From enrollment to the end of the intervention at 3 weeks

Secondary outcomes

1

The changes of the Berg Balance Scale (BBS) from baseline to the end of the intervention

The minimum and maximum values of the Berg Balance Scale are 0 and 56 points, respectively. The higher the score, the better the balance ability, and the lower the risk of falling.

Time frame
From enrollment to the end of the intervention at 3 weeks
2

The changes of the Mini-Mental State Examination (MMSE) from baseline to the end of the intervention

The minimum and maximum values of the Mini-Mental State Examination (MMSE) are 0 and 30 points, respectively. The higher the score, the better the cognitive function.

Time frame
From enrollment to the end of the intervention at 3 weeks
3

The changes of Trail making test from baseline to the end of the intervention

Time frame
From enrollment to the end of the intervention at 3 weeks
4

The changes of gait from baseline to the end of the intervention

The gait of participants is measured using insole plantar pressure measurement systems to assess the step length, cadence, walking speed, and plantar pressure distribution. The results could determine whether gait abnormalities are present.

Time frame
From enrollment to the end of the intervention at 3 weeks

Other outcomes

1

The changes of the Falls Efficacy Scale-International (FES-I) from baseline to the end of the intervention

The minimum and maximum values of the Falls Efficacy Scale-International (FES-I) are 16 and 64 points, respectively. A higher score indicates a greater degree of an individual's concern about falling.

Time frame
From enrollment to the end of the intervention at 3 weeks
2

The changes of 12-Item Health Survey from baseline to the end of the intervention

Time frame
From enrollment to the end of the intervention at 3 weeks
3

The changes of the Geriatric Depression Scale (GDS) from baseline to the end of the intervention

The minimum and maximum scores of the Geriatric Depression Scale (GDS) are 0 and 30 points, respectively. A higher score indicates more severe depressive symptoms in individuals.

Time frame
From enrollment to the end of the intervention at 3 weeks

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jinyao Wang

Lead sponsor

West China Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: